Elisabetta Sciacca

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Felice Rivellese, Anna E. A. Surace, Katriona Goldmann et al. · Nature Medicine · 2022 · 279 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Recapitulating thyroid cancer histotypes through engineering embryonic stem cells

Veronica Veschi, Alice Turdo, Chiara Modica et al. · Nature Communications · 2023 · 35 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Axl and MerTK regulate synovial inflammation and are modulated by IL-6 inhibition in rheumatoid arthritis

Alessandra Nerviani, Marie‐Astrid Boutet, Giulia Maria Ghirardi et al. · Nature Communications · 2024 · 30 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell–Targeted Therapy in the Trial of Anti–B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS)

Elena Pontarini, Elisabetta Sciacca, Farzana Chowdhury et al. · Arthritis & Rheumatology · 2023 · 23 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

NKp30 Receptor Upregulation in Salivary Glands of Sjögren’s Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment

Elena Pontarini, Elisabetta Sciacca, Sofia Grigoriadou et al. · Frontiers in Immunology · 2021 · 22 citations · Full text

Life Sciences, Immunology, Molecular Genetics +17